Home › NDC Lookup › RxCUI directory › RxCUI 1721283

1 ML talimogene laherparepvec 1000000 UNT/ML Injection [Imlygic] — RxCUI 1721283

RxNorm drug concept · Semantic branded drug
RxCUI 1721283 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1721283
Official name1 ML talimogene laherparepvec 1000000 UNT/ML Injection [Imlygic]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Imlygic 1000000 UNT/ML Injection; IMLYGIC 1,000,000 PFU in 1 mL Injection; Imlygic 1,000,000 PFU per 1 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)22 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1 ML talimogene laherparepvec 1000000 UNT/ML Inj... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML talimogene laherparepvec 1000000 UNT/ML Injection [Imlygic] RxCUI 1721283

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Herpesvirus 1, human 1316105
    • Talimogene laherparepvec 1721264
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Imlygic 1721279
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Herpesvirus 1, human Injection 1721277
    • Talimogene laherparepvec Injection 2648140
    • Herpesvirus 1, human Injectable Product 1721276
    • Talimogene laherparepvec Injectable Product 2661001
    • Herpesvirus 1, human Injection [Imlygic] 1721281
    • Talimogene laherparepvec Injection [Imlygic] 2654972
    • Imlygic Injectable Product 1721282
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML talimogene laherparepvec 1000000 UNT/ML Injection SCD · 1721278
  • Talimogene laherparepvec 1000000 UNT/ML SCDC · 2174190
  • Herpesvirus 1, human Injection SCDF · 1721277
  • Talimogene laherparepvec Injection SCDFP · 2648140
  • Herpesvirus 1, human Injectable Product SCDG · 1721276
  • Talimogene laherparepvec Injectable Product SCDGP · 2661001

Brand-Name Concepts

  • Talimogene laherparepvec 1000000 UNT/ML [Imlygic] SBDC · 2174192
  • Herpesvirus 1, human Injection [Imlygic] SBDF · 1721281
  • Talimogene laherparepvec Injection [Imlygic] SBDFP · 2654972
  • Imlygic Injectable Product SBDG · 1721282
  • Imlygic BN · 1721279

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1721283 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55513-0078-01 1 VIAL in 1 CARTON (55513-078-01) / 1 mL in 1 VIAL Imlygic Amgen Inc 2015-11-02
55513-0079-01 1 VIAL in 1 CARTON (55513-079-01) / 1 mL in 1 VIAL Imlygic Amgen Inc 2015-11-02
Observed labelers: Amgen Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9325 Inj talimogene laherparepvec 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.